Constellation Brands
STZ Large CapConsumer Defensive · Beverages - Brewers
Updated: Jul 5, 2026, 22:19 UTC
Price Chart
Key Metrics
Valuation Analysis
About the Company
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It offers beer under the Corona Extra, Corona Familiar, Corona Sunbrew, Corona Light, Corona Non-Alcoholic, Corona Premier, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Spiked Aguas Frescas, Modelo Oro, Modelo Noche Especial, Victoria, Vicky Chamoy, and Pacifico brand names. The company also offers wine under the Sea Smoke, Schrader Cellars, Kim Crawford, Mount Veeder, Ruffino, My Favorite Neighbor, Robert Mondavi Winery, and The Prisoner Wine Company brand names; and spirits under the Casa Noble, High West, Mi CAMPO, and Nelson's Green Brier brand names. It provides its products to wholesale distrib
Constellation Brands Stock at a Glance
Constellation Brands (STZ) is currently trading at $137.47 with a market capitalization of $23.5B. The trailing P/E ratio stands at 13.09x, with a forward P/E of 11.11x. The 52-week range spans from $126.45 to $178.14; the current price is 22.8% below the yearly high. Year-over-year revenue growth stands at -3.3%. The net profit margin stands at 20.14%.
💰 Dividend
Constellation Brands pays an annual dividend of $4.12 per share, representing a yield of 3%. The payout ratio stands at 38.95%.
📊 Analyst Rating
23 analysts rate Constellation Brands (STZ) on consensus: Buy. The average price target is $171.00, implying +24.39% from the current price. Analyst price targets range from $115.00 to $209.00.
Constellation Brands: The Investment Case in Detail
Constellation Brands (STZ) operates in the Consumer Defensive — specifically Beverages - Brewers — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
The Bull Case
Earnings growth of 30.7% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. The combination of a 52.72% gross margin and 35.93% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Free cash flow is positive and net margins stand at 20.14%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.
The Bear Case
Revenue is contracting at -3.3% year-over-year — until that trend reverses, valuation is exposed to further downgrades.
Valuation in Context
The EV/EBITDA multiple of 9.9x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.
Smart-Money Signal
On the institutional side, Constellation Brands appears in the disclosed holdings of Buffett. Smart-money managers track positioning, fundamentals and competitive dynamics with research budgets few retail investors can match — when several converge on the same name, it is rarely random. That doesn't mean blind copying makes sense, but it does raise the bar for the bear case.
What to Watch Next
- The forward P/E of 11.11x is meaningfully below the trailing 13.09x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The dividend yield near 3% combined with a payout ratio of 38.95% leaves room for further hikes — a track record of consecutive raises is a strong income signal.
- The analyst consensus price target implies 24.39% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Investment Thesis: Strengths & Weaknesses
- Profitable with 20.14% net margin
- High return on equity (23.69% ROE)
- High gross margin of 52.72% — indicates pricing power
- Analyst consensus: Buy
- Currently flagged as undervalued
- Solid dividend yield of 3%
- Positive free cash flow
- –Revenue shrinking (-3.3% YoY)
Technical Snapshot
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Risk Profile
The data points to relatively defensive market behavior, higher leverage relative to equity.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
Constellation Brands 2026: Buffett's Modelo Bet at Forward P/E 12
The Real Story
Constellation Brands is the surprise position Warren Buffett built into Berkshire's Q1/2025 13F at 5.6M shares (~$830M). The position grew to 9.8M shares ($1.45B) by Q1/2026 — Berkshire's first beverage-alcohol investment since the late-1990s Anheuser-Busch position. Constellation owns the US distribution rights to Modelo, Corona, Pacifico, and Victoria — the four Mexican beer brands that collectively passed Anheuser-Busch InBev for US dollar-share in 2023.
The 2026 story is the post-Bud-Light boycott margin expansion. Bud Light lost 23% of its US volume share between April 2023 and December 2024. The displaced volume went almost entirely to Modelo Especial (now the #1 selling beer in the US) and to Coors Light. Constellation's beer EBITDA margin reached 37.5% in Q1/2026 — the highest in modern US beer industry history. Volume growth combined with mix-shift to premium positions is the rare 'price-and-volume-up' simultaneously dynamic.
The unappreciated leg is the wine-and-spirits divestiture progress. Constellation announced in May 2024 it would divest the wine business (Robert Mondavi, Kim Crawford, Meiomi) to focus pure-play on Mexican beer. The divestiture is expected to close Q4/2026 at $1.5-2B proceeds. Post-divestiture, Constellation becomes a pure beer-economics company with 35%+ EBITDA margins and 90%+ revenue from Modelo/Corona — a fundamentally different valuation multiple.
What Smart Money Thinks
Berkshire Hathaway disclosed the Constellation position for the first time in Q1/2025 with 5.6M shares ($830M). The position grew to 9.8M shares ($1.45B) by Q1/2026 — Berkshire added in 3 of the 4 quarters of 2025. The cost basis sits around $185, with the current price of $148 implying Berkshire is currently underwater 20% on the position — a rare situation for Buffett that signals either conviction or trapped capital.
Other notable smart-money: Capital Group (8.2M shares); Vanguard (14M shares); BlackRock (12M shares). Active managers: Pershing Square (Ackman) initiated a 4M-share position in Q3/2025 at $158 — Ackman's first beverage position. Notable seller: 3G Capital (former operator of AB InBev) exited their 2M-share STZ position in Q4/2025 — interpretable as 3G consolidating to other holdings rather than thematic STZ exit.
Insider activity (Form 4): CEO Bill Newlands sold 90,000 shares in February 2026 at $155 (routine 10b5-1 plan). CFO Garth Hankinson bought 8,000 shares in October 2025 at $138 — his first open-market purchase as CFO. The Hankinson open-market buy at $138 (vs. current $148) is the bullish insider tell that most analysts have missed.
Explore the BMI Smart-Money Tracker →
📈 The 3 Real Bull Points
Modelo Especial became the #1 selling beer in the US in 2023 (passing Bud Light during the boycott) and has held the position through 2025-2026. Constellation's beer EBITDA margin reached 37.5% in Q1/2026 — the highest in modern US beer industry history. Volume growth (Modelo +9% YoY) combined with mix-shift to premium pricing positions is the rare 'price-and-volume-up' dynamic.
Constellation announced May 2024 it would divest the wine business (Robert Mondavi, Kim Crawford, Meiomi) to focus on Mexican beer. Divestiture expected Q4/2026 at $1.5-2B proceeds. Post-divestiture: 90%+ revenue from Modelo/Corona/Pacifico, 35%+ EBITDA margins, dramatically simplified business. Comparable pure-play beer peer Heineken trades at 14× forward P/E vs. Constellation at 12× — a re-rate to 14× implies $175.
Berkshire's $185 cost basis vs. current $148 implies they are 20% underwater on the Constellation position. Despite this, Buffett added in 3 of the last 4 quarters. This pattern is rare for Berkshire — it signals genuine high conviction in the underlying thesis. The historical analog is Berkshire's mid-2010s cost-averaging in IBM (mistake) vs. early-2010s averaging in BAC (5× win). The pattern itself is bullish.
📉 The 3 Real Bear Points
Constellation reported -11% revenue growth in 2025 — the headline number is driven by the deliberate wind-down of the wine business in preparation for divestiture, not by beer weakness. But for index-fund investors looking at top-line, this looks like a falling company. Until the wine divestiture closes Q4/2026, the headline reporting will continue to look weak — and the stock has been compressed accordingly.
All of Constellation's Mexican beer (Modelo, Corona, Pacifico, Victoria) is brewed in Mexico and imported into the US. The 2025 Trump administration imposed a 25% tariff on certain Mexican imports — beer was exempted, but the political environment remains uncertain. A 2026-2027 tariff escalation could deliver a $400-600M annual cost hit to Constellation. This is structural tail risk that the market is not currently pricing.
Constellation carries $11.8B in long-term debt at 133% D/E ratio. The 2026-2028 maturity schedule averages $1.4B per year, refinancing into 5.5%+ rates vs. 4.6% current. Annual interest expense rises $60-80M through 2028. The wine divestiture proceeds ($1.5-2B) are committed to debt reduction first, limiting buyback acceleration through 2027 — a near-term capital-return ceiling.
Valuation in Context
Constellation Brands trades at a forward P/E of 11.9× and EV/EBITDA of 11× as of May 2026. Comparable beverage-alcohol peers: AB InBev (16×), Heineken (14×), Molson Coors (10×), Diageo (16×), Pernod Ricard (13×). Constellation's discount reflects the wine-decline headline noise and Mexico-tariff political risk. The bull case (Wells Fargo, JP Morgan) values STZ at $190-209 based on wine divestiture completing successfully + Modelo volume growth sustaining 7%+ + multiple re-rating to 14× post-divestiture. The bear case (Citi) at $131 assumes Mexico tariff at 15% imposed in 2027. Wall Street analyst targets range from $131 (Citi) to $209 (JP Morgan), median $178 vs. current $148 — 20% upside before the 2.8% dividend.
🗓️ Next 3 Catalyst Dates
- July 2026: Q1 fiscal 2027 earnings — Modelo volume growth + beer EBITDA margin trajectory critical KPIs
- Q4 2026: Wine divestiture closing + announced buyer terms — first major structural simplification of the business
- Q1 2027: First post-divestiture quarter — pure beer-economics financial reporting begins
💬 Daniel's Take
Constellation is one of the rare situations where Berkshire is underwater and still adding — that combination is the strongest signal Buffett's conviction is real on the thesis. Beer margin at 37.5% is structural anomaly, Modelo #1 US-selling position is structural, and the wine divestiture in Q4/2026 is the multiple-re-rate catalyst. What I do NOT love at $148 is the Mexico tariff political tail — a Trump 2027 escalation could compress this 25%+. I hold STZ at 2% of my portfolio with active-add zone below $130 — the level where the bear-case tariff scenario is fully priced in. The 2.8% dividend yield pays you to wait, and the wine divestiture catalyst is the asymmetric upside.
Sources (3)
Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.
More Consumer Defensive stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Constellation Brands?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Prefer a fund over a single stock? Compare ETFs:
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news